Jump to ContentJump to Main Navigation
Show Summary Details
More options …

Clinical Chemistry and Laboratory Medicine (CCLM)

Published in Association with the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM)

Editor-in-Chief: Plebani, Mario

Ed. by Gillery, Philippe / Lackner, Karl J. / Lippi, Giuseppe / Melichar, Bohuslav / Payne, Deborah A. / Schlattmann, Peter / Tate, Jillian R.

12 Issues per year


IMPACT FACTOR 2016: 3.432

CiteScore 2016: 2.21

SCImago Journal Rank (SJR) 2016: 1.000
Source Normalized Impact per Paper (SNIP) 2016: 1.112

Online
ISSN
1437-4331
See all formats and pricing
More options …
Volume 36, Issue 8

Issues

Molecular Diagnostics for Cardiovascular Disease

Chi-Pui Pang
Published Online: 2005-06-01 | DOI: https://doi.org/10.1515/CCLM.1998.106

Abstract

The etiology of cardiovascular diseases is known to be multi-factorial. Some forms of cardiovascular disease are influenced by unclear genetic factors but are predominantly affected by factors such as diet, obesity, cigarette smoking, diabetes mellitus and dyslipidaemia. Some are caused by specific gene defects, with environmental factors playing a precipitating role. Others result from complex gene-gene or gene-enviroment interactions. Advances in knowledge of the molecular genetics of lipidaemic and vascular disorders have identified gene aberrations that are associated with cardiovascular disease. Techniques in molecular biology have been applied for rapid and reliable detection of specific gene defects to provide unequivocal diagnosis beneficial for appropriate drug therapy and genetic counseling. Pre-symptomatic diagnosis is possible and carriers can be advised on effective preventive measures. However, prior to the provision of a molecular diagnostic service, all gene alterations associated with cardiovascular disease have to be identified and their prevalence established in a population. The number of mutations in so many causative genes is enormous. While more cost-effective laboratory methodologies will be developed in the future, it is also anticipated that more mutations with direct or indirect effects on cardiovascular disease will be discovered in different populations.

About the article

Published Online: 2005-06-01

Published in Print: 1998-08-01


Citation Information: Clinical Chemistry and Laboratory Medicine, Volume 36, Issue 8, Pages 605–614, ISSN (Print) 1434-6621, DOI: https://doi.org/10.1515/CCLM.1998.106.

Export Citation

Citing Articles

Here you can find all Crossref-listed publications in which this article is cited. If you would like to receive automatic email messages as soon as this article is cited in other publications, simply activate the “Citation Alert” on the top of this page.

[1]
Bao Jian Fan, Pancy Oi Sin Tam, Kwong Wai Choy, Dan Yi Wang, Dennis Shun Chiu Lam, and Chi Pui Pang
Clinical Biochemistry, 2006, Volume 39, Number 3, Page 231
[2]
Jeffrey S. Ross and Geoffrey S. Ginsburg
Drug Discovery Today, 2002, Volume 7, Number 16, Page 859
[3]
Chi-Pui Pang, Larry Baum, and Dennis S. C. Lam
Clinical Chemistry and Laboratory Medicine, 2000, Volume 38, Number 9
[4]
Lamia Rebhi, Asma Omezzine, Kaouther Kchok, Radhia Belkahla, Ibtihel Ben HadjMbarek, Jihen Rejeb, Nabila Ben Rejeb, Naoufel Nabli, Amina Bibi, Taieb Massoud, Ahmed Abdelaziz, Essia Boughzala, and Ali Bouslama
Clinical Chemical Laboratory Medicine, 2008, Volume 46, Number 3
[5]
Jeffrey S. Ross and Geoffrey S. Ginsburg
American Journal of Clinical Pathology, 2003, Volume 119, Number 1, Page 26

Comments (0)

Please log in or register to comment.
Log in